Health Care Activity – Page 3

2025 J.P. Morgan Healthcare Conference: Optimism, Innovation, and Shifting Landscapes

3 months ago talkbio0Tagged Administration occupational activities, ambulatory care services, Aortic Valve Insufficiency, deal activity, digital health, expansion, Gene Modification, Health care facility, Pharmaceutical Services, regulatory environment, Transplant Registry Unified Management Program

AI in healthcare, outpatient care expansion, pharmaceutical services, regulatory environment, deal activity, digital health, gene editing, Trump administration

Medicare Selects Ozempic, Wegovy for Price Negotiations: A Step Towards Lowering Prescription Drug Costs

3 months ago talkbio0Tagged drug price, Health care facility, Inflation, Mediation, Medicare, Prescription procedure, seniors, Wegovy

Medicare, drug price negotiations, Ozempic, Wegovy, Inflation Reduction Act, prescription drug costs, seniors, healthcare.

DEA Unveils Special Registration Framework for Telehealth Prescribing of Controlled Substances

3 months ago talkbio0Tagged controlled substance, DEA Special Registration, Flexibilities, Prescribed, regulatory, Telemedicine

DEA Special Registration, Telehealth Prescribing, Controlled Substances, Telemedicine Flexibilities, Ryan Haight Act, Telemedicine Regulations

FTC Targets Pharmacy Benefit Managers Over Exorbitant Price Hikes on Specialty Generic Drugs

3 months ago talkbio0Tagged Benefit, Financial cost, Health care facility, Hikes, manager, Pharmaceutical Services, Pharmacy Benefit Manager, Prices, specialty generic drugs, United States Federal Trade Commission

FTC, Pharmacy Benefit Managers, PBM, Specialty Generic Drugs, Price Hikes, Healthcare Costs

FTC Report Reveals Big 3 PBMs Made $7.3 Billion from Excessive Markups on Specialty Generic Drugs

3 months ago talkbio0Tagged Benefit, Big 3, FTC report, Health care facility, manager, PBMs, Pharmaceutical Services, Prices, specialty generic drugs

FTC report, Big 3 PBMs, Specialty generic drugs, Price markups, Healthcare costs, Pharmacy benefit managers

FDA Introduces New Guidance on AI for Drug Approval Submissions in 2025

4 months ago talkbio0Tagged Advice, Aortic Valve Insufficiency, Artificial Intelligence, Drug Approval, Drug Development, Medical Devices, regulatory decision-making, United States Food and Drug Administration

FDA, AI, drug approval, guidance, regulatory decision-making, medical devices, artificial intelligence, drug development

GLP-1 Medications: Balancing Efficacy and Concerns Amidst Celebrity Endorsements and Rising Demand

4 months ago talkbio0Tagged agonists, aspects of adverse effects, Diabetes Mellitus, Non-Insulin-Dependent, Employer, Endorsements, Famous Persons, Financial cost, Glucagon-Like Peptide 1, Health Planning, Long-term Safety, Weight Loss

GLP-1 agonists, Weight loss, Type 2 diabetes, Celebrity endorsements, Side effects, Long-term safety, Cost implications, Employer health plans

Healthcare Sector Winners and Losers in the 2024 Government Funding Bill

4 months ago talkbio0Tagged Government, Health care facility, hospital-at-home programs, Legislation, Medicaid, Medicare, pay, Payments, Physicians, shutdown, Symmetrical dyschromatosis of extremities, Telemedicine

Healthcare funding, government shutdown, telehealth, Medicare payments, Medicaid DSH, hospital-at-home programs, physician pay cuts, healthcare legislation.